The mammalian target of rapamycin (mTOR) functions in cells at least as two complexes, mTORC1 and mTORC2. Intensive studies have focused on the roles of mTOR in the regulation of cell proliferation, growth, and survival. Recently we found that rapamycin inhibits type I insulin-like growth factor (IGF-1)-stimulated lamellipodia formation and cell motility, indicating involvement of mTOR in regulating cell motility. This study was set to further elucidate the underlying mechanism. Here we show that rapamycin inhibited protein synthesis and activities of small GTPases (RhoA, Cdc42, and Rac1), crucial regulatory proteins for cell migration. Disruption of mTORC1 or mTORC2 by down-regulation of raptor or rictor, respectively, inhibited the activities of these proteins. However, only disruption of mTORC1 mimicked the effect of rapamycin, inhibiting their protein expression. Ectopic expression of rapamycin-resistant and constitutively active S6K1 partially prevented rapamycin inhibition of RhoA, Rac1, and Cdc42 expression, whereas expression of constitutively hypophosphorylated 4E-BP1 (4EBP1-5A) or down-regulation of S6K1 by RNA interference suppressed expression of the GTPases, suggesting that both mTORC1-mediated S6K1 and 4E-BP1 pathways are involved in protein synthesis of the GTPases. Expression of constitutively active RhoA, but not Cdc42 and Rac1, conferred resistance to rapamycin inhibition of IGF-1-stimulated lamellipodia formation and cell migration. The results suggest that rapamycin inhibits cell motility at least in part by down-regulation of RhoA protein expression and activity through mTORC1-mediated S6K1 and 4E-BP1-signaling pathways.The mammalian target of rapamycin (mTOR), 3 a member of the phosphoinositide 3Ј-kinase-related kinase family, is a central controller of cell proliferation, growth, and survival (1). Rapamycin can form a complex with FK506 binding protein 12 and then bind mTOR, selectively inhibiting its kinase activity and function (1). Recently, two mTOR complexes (mTORC1 and mTORC2) have been identified in mammalian cells (1). mTORC1 is composed of mTOR, mLST8 (also termed G-protein -subunit-like protein, GL, a yeast homolog of LST8), PRAS40 (proline-rich Akt substrate 40 kDa), and raptor (regulatory-associated protein of mTOR) and is rapamycin-sensitive (2-8). In response to growth factors and nutrients, mTORC1 regulates cell proliferation and growth by modulating many processes, including protein synthesis and ribosome biogenesis through downstream effectors like 4E-BP1 (eukaryotic initiation factor 4E-binding protein 1) and S6K1 (ribosomal p70 S6 kinase 1) (1, 9). mTORC2 consists of mTOR, mLST8, mSin1 (mammalian stress-activated protein kinase-interacting protein 1), rictor (rapamycin-insensitive companion of mTOR), and protor (protein observed with rictor; also named PRR5 (proline-rich protein 5)), and is rapamycin-insensitive (10 -16). mTORC2 phosphorylates Akt and PKC, signals to small GTPases (RhoA and Rac1), and controls cytoskeleton organization (11,(17)(18)(19)(20). Most recent...